Company · CIK 1574232
Addex Therapeutics Ltd.
| CIK | 1574232 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | V8 |
| Business address | Switzerland |
| Listed | ADXN (Nasdaq) |
| First annual or quarterly report | 2020-04-27 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291644 | 2025-11-19 | 2025-12-10 | 3 | |
| 333-271611 | 2023-05-03 | 2024-04-22 | 7 | |
| 333-255089 | 2021-04-07 | 2024-01-30 | 7 | |
| 333-262050 | 2022-01-07 | 2022-08-29 | 5 | |
| 333-266995 | 2022-08-19 | 2022-08-29 | 2 | |
| 333-235554 | 2019-12-17 | 2022-04-19 | 6 | |
| 333-251322 | 2020-12-14 | 2021-01-08 | 4 |
Filings
37| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-12-10 | 424B5Shelf takedown | 333-291644 | 0001104659-25-119967 |
| 2025-12-05 | EFFECTDeclared effective | 333-291644 | 9999999995-25-003556 |
| 2025-11-19 | F-3Shelf registered | 333-291644 | 0001104659-25-114077 |
| 2024-04-22 | EFFECTDeclared effective | 333-271611 | 9999999995-24-001061 |
| 2024-01-30 | 424B5Shelf takedown | 333-255089 | 0001104659-24-008319 |
| 2023-11-29 | EFFECTDeclared effective | 333-271611 | 9999999995-23-003479 |
| 2023-08-10 | EFFECTDeclared effective | 333-271611 | 9999999995-23-002338 |
| 2023-06-02 | EFFECTDeclared effective | 333-271611 | 9999999995-23-001619 |
| 2023-06-01 | F-1/AAmendment | 333-271611 | 0001104659-23-067020 |
| 2023-05-11 | F-1/AAmendment | 333-271611 | 0001104659-23-059096 |
| 2023-05-03 | F-1Registration filed | 333-271611 | 0001104659-23-055487 |
| 2023-04-04 | 424B5Shelf takedown | 333-255089 | 0001104659-23-041624 |
| 2022-08-29 | EFFECTDeclared effective | 333-266995 | 9999999995-22-002544 |
| 2022-08-29 | EFFECTDeclared effective | 333-262050 | 9999999995-22-002531 |
| 2022-08-19 | F-1Registration filed | 333-266995 | 0001104659-22-093004 |
| 2022-07-26 | 424B5Shelf takedown | 333-255089 | 0001104659-22-082766 |
| 2022-07-20 | 424B5Shelf takedown | 333-262050 | 0001104659-22-080927 |
| 2022-04-19 | EFFECTDeclared effective | 333-235554 | 9999999995-22-001013 |
| 2022-04-04 | EFFECTDeclared effective | 333-262050 | 9999999995-22-000815 |
| 2022-01-18 | EFFECTDeclared effective | 333-262050 | 9999999995-22-000163 |
| 2022-01-07 | F-1Registration filed | 333-262050 | 0001104659-22-002264 |
| 2021-12-20 | 424B5Shelf takedown | 333-255089 | 0001104659-21-151327 |
| 2021-06-30 | 424B5Shelf takedown | 333-255089 | 0001047469-21-001224 |
| 2021-04-13 | EFFECTDeclared effective | 333-255089 | 9999999995-21-001414 |
| 2021-04-07 | F-3Shelf registered | 333-255089 | 0001047469-21-000882 |
| 2021-01-08 | 424B4Final prospectus | 333-251322 | 0001047469-21-000043 |
| 2021-01-06 | EFFECTDeclared effective | 333-251322 | 9999999995-21-000043 |
| 2021-01-06 | F-1/AAmendment | 333-251322 | 0001047469-21-000017 |
| 2020-12-14 | F-1Registration filed | 333-251322 | 0001047469-20-005701 |
| 2020-10-13 | DRSDraft made public | 377-03653 | 0001410578-20-000137 |
| 2020-01-28 | 424B4Final prospectus | 333-235554 | 0001047469-20-000551 |
| 2020-01-27 | EFFECTDeclared effective | 333-235561 | 9999999995-20-000167 |
| 2020-01-27 | EFFECTDeclared effective | 333-235554 | 9999999995-20-000166 |
| 2020-01-23 | F-1/AAmendment | 333-235554 | 0001047469-20-000443 |
| 2020-01-14 | F-1/AAmendment | 333-235554 | 0001047469-20-000221 |
| 2019-12-17 | F-1Registration filed | 333-235554 | 0001047469-19-006857 |
| 2019-09-24 | DRSDraft made public | 377-02847 | 0000912057-19-000390 |